Evidence map›Paper›PMID 26929379›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Disruption of lipid homeostasis in the Gram-negative cell envelope activates a novel cell death pathway.

Holly A Sutterlin, Handuo Shi, Kerrie L May, Amanda Miguel, Somya Khare, Kerwyn Casey Huang, Thomas J Silhavy

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 176 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. From Environmental Organism to Nosocomial Threat:Antibiotics (Basel, Switzerland) · 2026
    Review
  6. Article
  7. Article
  8. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Control of theJournal of bacteriology · 2025
    Article
  13. Article
  14. Following phospholipid transfer through the OmpFProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Holly A SutterlinDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544;
Handuo ShiDepartment of Bioengineering, Stanford University, Stanford, CA 94305;
Kerrie L MayDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544;
Amanda MiguelDepartment of Bioengineering, Stanford University, Stanford, CA 94305;
Somya KhareDepartment of Bioengineering, Stanford University, Stanford, CA 94305; Lynbrook High School, San Jose, CA 95129;
Kerwyn Casey HuangDepartment of Bioengineering, Stanford University, Stanford, CA 94305; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305 tsilhavy@princeton.edu kchuang@stanford.edu.
Thomas J SilhavyDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544; tsilhavy@princeton.edu kchuang@stanford.edu.
Stanford University · USPrinceton University · US

Funding

TRAINING & OUTREACH COREP50GM107615 · NIGMS · STANFORD UNIVERSITY · PI SCOTT, MATTHEW P. · 2013 to 2017
$10.9M
GENETIC ANALYSIS OF PROTEIN EXPORTR37GM034821 · NIGMS · PRINCETON UNIVERSITY · PI SILHAVY, THOMAS J. · 1999 to 2008
$4.9M
GENETIC ANALYSIS OF PROTEIN EXPORTR01GM034821 · NIGMS · PRINCETON UNIVERSITY · PI SILHAVY, THOMAS J. · 1985 to 2015
$4.7M
Engineering of cell shape and intracellular organizationDP2OD006466 · OD · STANFORD UNIVERSITY · PI HUANG, KERWYN C. · 2009 to 2009
$2.4M
NIGMS NIH HHS GM34821NIGMS NIH HHS P50 GM107615NIGMS NIH HHS R01 GM034821NIGMS NIH HHS R37 GM034821NIH HHS DP2 OD006466NIH HHS DP2OD006466
6 · The paper itself

Abstract

Gram-negative bacteria balance synthesis of the outer membrane (OM), cell wall, and cytoplasmic contents during growth via unknown mechanisms. Here, we show that a dominant mutation (designated mlaA*, maintenance of lipid asymmetry) that alters MlaA, a lipoprotein that removes phospholipids from the outer leaflet of the OM of Escherichia coli, increases OM permeability, lipopolysaccharide levels, drug sensitivity, and cell death in stationary phase. Surprisingly, single-cell imaging revealed that death occurs after protracted loss of OM material through vesiculation and blebbing at cell-division sites and compensatory shrinkage of the inner membrane, eventually resulting in rupture and slow leakage of cytoplasmic contents. The death of mlaA* cells was linked to fatty acid depletion and was not affected by membrane depolarization, suggesting that lipids flow from the inner membrane to the OM in an energy-independent manner. Suppressor analysis suggested that the dominant mlaA* mutation activates phospholipase A, resulting in increased levels of lipopolysaccharide and OM vesiculation that ultimately undermine the integrity of the cell envelope by depleting the inner membrane of phospholipids. This novel cell-death pathway suggests that balanced synthesis across both membranes is key to the mechanical integrity of the Gram-negative cell envelope.

Indexed as

Bacterial Outer Membrane ProteinsCell MembraneCell WallEscherichia coliEscherichia coli ProteinsFatty AcidsLipid MetabolismLipopolysaccharidesMagnesiumMutationPermeabilityPhospholipases A1PhospholipidsBacterial Outer Membrane ProteinsEscherichia coli ProteinsFatty AcidsLipopolysaccharidesMagnesiumouter membrane phospholipase APhospholipases A1Phospholipidslipid transportlipopolysaccharidelysophospholipidsouter membranesingle-cell imaging

Identifiers

PMID26929379
PMCPMC4801249
OpenAlexW2290251038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.